Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
03/1996
03/21/1996WO1996008256A1 2',5' phosphorothioate/phosphodiester oligoadenylates and antiviral uses thereof
03/21/1996WO1996008247A1 Anti-helicobacter agent
03/21/1996CA2199867A1 Methods and compositions for identifying streptococcus containing a cysteine protease or fragment thereof
03/21/1996CA2198900A1 Intermediates for dinucleotide and oligonucleotide analogues
03/20/1996EP0702085A1 Recombinant infectious non-segmented negative strand RNA virus
03/20/1996EP0702084A1 Recombinant retroviruses
03/20/1996EP0701818A2 Therapeutic methods using catalytic antibodies
03/20/1996EP0701612A1 IMMUNOGENIC FORMULATION OF OspC ANTIGEN VACCINES FOR THE PREVENTION AND TREATMENT OF LYME DISEASE AND RECOMBINANT METHODS FOR THE PREPARATION OF SUCH ANTIGENS
03/20/1996EP0701572A1 Composite synthetic peptide construct eliciting neutralizing antibodies and cytotoxic t lymphocytes against hiv
03/20/1996EP0701564A1 Bifunctional nucleosides, oligomers thereof, and methods of making and using the same
03/20/1996EP0701557A1 Lavendamycin analogs, their use and preparation
03/20/1996EP0701447A1 Cyclohexapeptidyl propanolamine compounds
03/20/1996EP0701446A1 Hemoregulatory peptides
03/20/1996EP0701439A1 Stable copper(i) complexes and methods related thereto
03/20/1996EP0389521B1 2',5'-phosphorothioate oligoadenylates and antiviral uses thereof
03/20/1996EP0355140B1 Human monoclonal anti-hiv-i-antibodies
03/20/1996EP0280710B1 Dna encoding the t cell surface protein t4 and use of fragments of t4 in the treatment of aids
03/20/1996CN1119026A Fibronectin binding protein; monoclonal antibody and their use in preventing bacterial adhesion
03/20/1996CN1119017A Oligodeoxynucleotides containing 5-alkyl-,5(1-alkenyl)- and 5-(1-alkynyl)pyrimidines and pharmaceutical compositions containing such compounds
03/20/1996CN1119016A Crystalline ceftiofur free acid
03/20/1996CA2158076A1 Antitumor antibiotic compounds; hayumicins and analogs thereof
03/19/1996CA1338171C Antibiotic, mersacidin, a process for the preparation thereof and the use thereof as a pharmaceutical
03/19/1996CA1338170C Ab-011 antibiotics and process for producing them
03/19/1996CA1338168C Antibiotic ll-e19020 alpha and beta
03/14/1996WO1996007741A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
03/14/1996WO1996007739A2 Interleukin-1 type 3 receptors
03/14/1996WO1996007667A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids
03/14/1996WO1996007646A1 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
03/14/1996WO1996007430A1 Therapeutic treatment of clostridium difficile associated diseases
03/14/1996WO1996007427A1 Capsular polysaccharide immunomodulator
03/14/1996WO1996007426A1 Enteral vaccine for vaginal infections
03/14/1996WO1996007408A1 Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt
03/14/1996WO1996007403A1 Depressant of functions developed by molecule
03/14/1996WO1996007392A2 Oligonucleotide prodrugs
03/14/1996WO1996004378A3 Chimeric proteins and muteins of tissue factor pathway inhibitors tfpi and tfpi-2
03/14/1996WO1996002229A3 Soap composition
03/14/1996WO1995035111A3 USE OF βGalNac(1-4)βGal CONJUGATES TO TREAT CANDIDA INFECTION
03/14/1996CA2199609A1 Interleukin-1 type 3 receptors
03/14/1996CA2199502A1 Antiviral nucleoside analogues containing a substituted benzimidazole base attached to a carbocyclic ring
03/14/1996CA2199464A1 Oligonucleotide prodrugs
03/14/1996CA2199255A1 Enteral vaccine for vaginal infections
03/14/1996CA2199253A1 Novel crystal of cephalosporin compound
03/14/1996CA2198621A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules
03/14/1996CA2197785A1 Oligonucleotide conjugates, compositions and methods for splitting ribonucleic acids
03/14/1996CA2197714A1 Therapeutic treatment of clostridium difficile associated diseases
03/13/1996EP0700998A1 Recombinant mersacidin and a method for production
03/13/1996EP0700991A1 Commercial scale concentrated preharvest tissue culture produced live T. Gondii bradyzoite and products and processes
03/13/1996EP0700928A1 Nucleic acid-binding oligomers for therapy and diagnostics
03/13/1996EP0700911A1 Imidazole derivatives having anti-HIV activity
03/13/1996EP0700440A1 Regulator of contact-mediated hemolysin
03/13/1996EP0700439A1 Lymphocyte chemoattractant factor and uses thereof
03/13/1996EP0700430A1 Methods for selectively stimulating proliferation of t cells
03/13/1996EP0700287A1 Arylating medicaments
03/13/1996EP0700249A1 Anti-infective agents
03/13/1996EP0540613B1 Products and processes for the treatment of the alimentary canal
03/13/1996EP0521974B1 Veterinary treatment
03/13/1996EP0489108B1 Use of spiperone derivatives for immunosuppression
03/13/1996EP0469036B1 Composition and treatment with biologically active peptides and antibiotic
03/13/1996EP0439513B1 Composition for inhibiting transmission of aids
03/13/1996EP0436545B1 Therapeutic methods using catalytic antibodies
03/13/1996CN1118601A Inhibitors of herpes viral ribonucleotide reductase
03/13/1996CN1118573A Peptides for inducing cytotoxic T lymphocyte responses to hepatitis B virus
03/13/1996CN1118349A Oxime derivatives of cephalosporanic structure and compounds for their preparation
03/13/1996CN1118251A Skin spraying sterilizing agent
03/12/1996US5498788 Inclusion complexes of clavulanic acid and of potassium salts thereof with hydrophobic β-cyclodextrin derivatives a process for the preparation thereof
03/12/1996US5498729 Prodrug compositions
03/12/1996US5498699 Complexes and chelates of azithromycin with bivalent and/or trivalent metals and their use as antiulcer
03/12/1996US5498633 Esters of acyl carnitines with long-chain aliphatic alcohols and pharmaceutical compositions containing same having antibacterial activity
03/12/1996US5498632 Bactericides
03/12/1996US5498602 Viricide active against hiv
03/12/1996CA2092402C Anticoccidial and growth promoting polycyclic ether antibiotic
03/12/1996CA1338143C Enzymatic preparation of clavulanic acid and its precursor
03/07/1996WO1996006959A1 System for electrolyzing fluids for in vivo administration to humans and other warm blooded mammals
03/07/1996WO1996006941A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996WO1996006937A1 Improvements in production of proteins in host cells
03/07/1996WO1996006934A1 Infectious peritonitis vaccine
03/07/1996WO1996006860A2 Gradual modification, super-agonists and antagonists of signal-proteins and peptides
03/07/1996WO1996006857A1 Immunostimulatory agents
03/07/1996WO1996006848A1 NEW THIAZOLO[3,2-a]QUINOLINE AND THIAZOLO[3,2-a]NAPHTHYRIDINE DERIVATIVES
03/07/1996WO1996006844A1 4-(2-amino-6-(cyclopropylamino)-9h-purin-9-yl)-2-cyclopentene-1-methanol succinate as antiviral agent
03/07/1996WO1996006630A1 Methods and compositions for modulating a t cell response
03/07/1996WO1996006627A1 Mutant enterotoxin effective as a non-toxic oral adjuvant
03/07/1996WO1996006620A2 Lipid analogs for treating viral infections
03/07/1996WO1996006619A1 Polynucleic acids and proteins from a porcine reproductive and respiratory syndrome virus and uses thereof
03/07/1996WO1996006532A1 A basic protein composition for killing or inhibiting microbial cells
03/07/1996WO1996006528A1 Ionene polymers containing biologically-active anions
03/07/1996WO1996004385A3 Purified hepatitis c virus envelope proteins for diagnostic and therapeutic use
03/07/1996WO1995019777A3 Use of diesters of muramyl peptides in oral form as immunostimulating agents
03/07/1996DE4431122A1 Neue Thiazolo[3,2-a]chinolin- und -naphthyridinderivate New thiazolo [3,2-a] quinoline and -naphthyridinderivate
03/07/1996DE19532001A1 New antibacterial peptide, moricin, from silkworms
03/07/1996CA2198919A1 Gradual modification, super agonists and antagonists of signs and peptides
03/07/1996CA2198891A1 Genetically modified t cells
03/07/1996CA2198616A1 New thiazolo[3,2-a]quinoline and thiazolo[3,2-a]naphthyridine derivatives
03/07/1996CA2198499A1 System for electrolyzing fluids for in vivo administration to humans and other warm blooded mammals
03/07/1996CA2198462A1 Genetic therapy of diseases caused by the immune system, said therapy using a cell-specific active substance regulated by the cell cycle
03/07/1996CA2198345A1 Improvements in production of proteins in host cells
03/06/1996EP0699758A1 Prototype felv isolates for use in disease models and vaccines
03/06/1996EP0699751A1 Antisense complementary to HCV genome
03/06/1996EP0699682A1 Process for the preparation and/or purification of clavulanic acid
03/06/1996EP0699681A1 Cephalosporin derivatives
1 ... 1616 1617 1618 1619 1620 1621 1622 1623 1624 1625 1626 1627 1628 1629 1630 1631 1632 1633 1634 1635 1636 ... 1798